{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:59:01Z","timestamp":1791410341666,"version":"4.3.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The real-time quaking-induced conversion (RT-QuIC) assay has revolutionized prion disease diagnosis by detecting amyloidogenic PrP conformers in different tissue types and body fluids. Recently, we achieved a breakthrough by detecting amyloidogenic PrP conformers in tear fluid (TF), a non-invasive biofluid, warranting further evaluation. We refined our RT-QuIC protocol to assess seeding conversion efficiency using various recombinant substrates, including full-length human (FL Hu), and mutant versions linked to genetic prion diseases, such as E200K and D178N, in both CSF and TF samples. Our study included patients with sporadic and familial prion diseases. FL Hu E200K showed the highest seeding efficiency in cerebrospinal fluid (CSF), with sensitivity increasing from 78 to 93% for symptomatic Creutzfeldt\u2013Jakob disease (CJD) and from 19 to 75% for fatal familial insomnia (FFI) compared with the hamster-sheep substrate. For tear fluid, diagnostic sensitivity was 85% for sCJD and 64% for symptomatic genetic prion diseases, the assay was also able to detect amyloidogenic PrP in 57% of the healthy mutation carriers (HMC, persons at risk without symptoms). We validated the diagnostic accuracy of the TF RT-QuIC from our previous study (cohort 1) in a second independent study. Additionally, we confirmed that TF RT-QuIC requires FL Hu E200K substrates since hamster-sheep failed in detection of seeding activity in tears. Notably, only 1 out of 184 controls without prion disease tested positive. Studies comparing different disease stages (early vs. late) showed that later stages produced a stronger signal response. Our study demonstrates that the FL Hu E200K rec PrP substrate improves RT-QuIC sensitivity in CSF diagnostics and validates the reliable detection of seeding activity in TF in two cohorts as well as in HMC.<\/jats:p>","DOI":"10.1186\/s40478-025-02212-8","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:15:50Z","timestamp":1769120150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid"],"prefix":"10.1186","volume":"14","author":[{"given":"Susana Da Silva","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Gerecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lisa","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgi","family":"Canaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasier","family":"Era\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Da Silva Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2212_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178. https:\/\/doi.org\/10.1038\/nm.2294","journal-title":"Nat Med"},{"key":"2212_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","volume":"74","author":"M Bongianni","year":"2017","unstructured":"Bongianni M, Orru C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, Triva G, Capaldi S, Testi S, Ferrari S et al (2017) Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol 74:155\u2013162. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4614","journal-title":"JAMA Neurol"},{"key":"2212_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1257","volume":"8","author":"D Bougard","year":"2016","unstructured":"Bougard D, Brandel JP, Belondrade M, Beringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A et al (2016) Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 8:370ra182. https:\/\/doi.org\/10.1126\/scitranslmed.aag1257","journal-title":"Sci Transl Med"},{"key":"2212_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJMc2000687","volume":"383","author":"JP Brandel","year":"2020","unstructured":"Brandel JP, Vlaicu MB, Culeux A, Belondrade M, Bougard D, Grznarova K, Denouel A, Plu I, Bouaziz-Amar E, Seilhean D et al (2020) Variant Creutzfeldt-Jakob disease diagnosed 7.5 years after occupational exposure. N Engl J Med 383:83\u201385. https:\/\/doi.org\/10.1056\/NEJMc2000687","journal-title":"N Engl J Med"},{"key":"2212_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise N, Schmitz M, Llorens F, Villar-Pique A, Cramm M, Thom T, da Silva Correia SM, da Cunha JEG, Mobius W, Outeiro TF et al (2019) Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol 85:691\u2013703. https:\/\/doi.org\/10.1002\/ana.25446","journal-title":"Ann Neurol"},{"key":"2212_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6188","volume":"8","author":"L Concha-Marambio","year":"2016","unstructured":"Concha-Marambio L, Pritzkow S, Moda F, Tagliavini F, Ironside JW, Schulz PE, Soto C (2016) Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 8:370ra183. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6188","journal-title":"Sci Transl Med"},{"key":"2212_CR7","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D, Kim YS, Satoh K et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53:1896\u20131904. https:\/\/doi.org\/10.1007\/s12035-015-9133-2","journal-title":"Mol Neurobiol"},{"key":"2212_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","volume":"51","author":"M Cramm","year":"2015","unstructured":"Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, Schroeder B, Raeber A, Kuhn F, Zerr I (2015) Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol 51:396\u2013405. https:\/\/doi.org\/10.1007\/s12035-014-8709-6","journal-title":"Mol Neurobiol"},{"key":"2212_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00441-022-03715-9","volume":"392","author":"SM Da Silva Correia","year":"2023","unstructured":"Da Silva Correia SM, Schmitz M, Fischer A, Hermann P, Zerr I (2023) Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease. Cell Tissue Res 392:301\u2013306. https:\/\/doi.org\/10.1007\/s00441-022-03715-9","journal-title":"Cell Tissue Res"},{"key":"2212_CR10","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","volume":"7","author":"A Franceschini","year":"2017","unstructured":"Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, Capellari S, Green A, Giaccone G, Caughey B et al (2017) High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep 7:10655. https:\/\/doi.org\/10.1038\/s41598-017-10922-w","journal-title":"Sci Rep"},{"key":"2212_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, Green A, Haik S, Kovacs GG, Ladogana A et al (2021) Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 20:235\u2013246. https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4","journal-title":"Lancet Neurol"},{"key":"2212_CR12","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00415-022-11549-2","volume":"270","author":"P Hermann","year":"2023","unstructured":"Hermann P, Schmitz M, Cramm M, Goebel S, Bunck T, Schutte-Schmidt J, Schulz-Schaeffer W, Stadelmann C, Matschke J, Glatzel M et al (2023) Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance. J Neurol 270:2149\u20132161. https:\/\/doi.org\/10.1007\/s00415-022-11549-2","journal-title":"J Neurol"},{"key":"2212_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo A, Fairfoul G, Ayudhaya ACN, Serradell M, Gelpi E, Vilaseca I, Sanchez-Valle R, Gaig C, Santamaria J, Tolosa E et al (2021) Detection of alpha-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol 20:203\u2013212. https:\/\/doi.org\/10.1016\/S1474-4422(20)30449-X","journal-title":"Lancet Neurol"},{"key":"2212_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s11357-022-00576-6","volume":"44","author":"CW Lin","year":"2022","unstructured":"Lin CW, Lai TT, Chen SJ, Lin CH (2022) Elevated alpha-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson\u2019s disease. Geroscience 44:1551\u20131562. https:\/\/doi.org\/10.1007\/s11357-022-00576-6","journal-title":"Geroscience"},{"key":"2212_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","volume":"73","author":"C Luk","year":"2016","unstructured":"Luk C, Jones S, Thomas C, Fox NC, Mok TH, Mead S, Collinge J, Jackson GS (2016) Diagnosing sporadic Creutzfeldt-Jakob disease by the detection of abnormal prion protein in patient urine. JAMA Neurol 73:1454\u20131460. https:\/\/doi.org\/10.1001\/jamaneurol.2016.3733","journal-title":"JAMA Neurol"},{"key":"2212_CR16","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1038\/s41598-020-65503-1","volume":"10","author":"F Maass","year":"2020","unstructured":"Maass F, Rikker S, Dambeck V, Warth C, Tatenhorst L, Csoti I, Schmitz M, Zerr I, Leha A, Bahr M et al (2020) Increased alpha-synuclein tear fluid levels in patients with Parkinson\u2019s disease. Sci Rep 10:8507. https:\/\/doi.org\/10.1038\/s41598-020-65503-1","journal-title":"Sci Rep"},{"key":"2212_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/acn3.51000","volume":"7","author":"A Mammana","year":"2020","unstructured":"Mammana A, Baiardi S, Rossi M, Franceschini A, Donadio V, Capellari S, Caughey B, Parchi P (2020) Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients. Ann Clin Transl Neurol 7:559\u2013564. https:\/\/doi.org\/10.1002\/acn3.51000","journal-title":"Ann Clin Transl Neurol"},{"key":"2212_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00292-25","volume":"13","author":"A Marin-Moreno","year":"2025","unstructured":"Marin-Moreno A, Reine F, Jaffrezic F, Herzog L, Rezaei H, Quadrio I, Haik S, Beringue V, Martin D (2025) Human PrP E219K: a new and promising substrate for robust RT-QuIC amplification of human prions with potential for strain discrimination. Microbiol Spectr 13:e0029225. https:\/\/doi.org\/10.1128\/spectrum.00292-25","journal-title":"Microbiol Spectr"},{"key":"2212_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orru CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG et al (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 72:278\u2013285. https:\/\/doi.org\/10.1002\/ana.23589","journal-title":"Ann Neurol"},{"key":"2212_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1056\/NEJMoa1404401","volume":"371","author":"F Moda","year":"2014","unstructured":"Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park KW, Maderna E, Suardi S, Haik S, Brandel JP et al (2014) Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med 371:530\u2013539. https:\/\/doi.org\/10.1056\/NEJMoa1404401","journal-title":"N Engl J Med"},{"key":"2212_CR21","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1038\/s41598-021-84527-9","volume":"11","author":"TH Mok","year":"2021","unstructured":"Mok TH, Nihat A, Luk C, Sequeira D, Batchelor M, Mead S, Collinge J, Jackson GS (2021) Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases. Sci Rep 11:5231. https:\/\/doi.org\/10.1038\/s41598-021-84527-9","journal-title":"Sci Rep"},{"key":"2212_CR22","doi-asserted-by":"publisher","unstructured":"Mok TH, Nihat A, Majbour N, Sequeira D, Holm-Mercer L, Coysh T, Darwent L, Batchelor M, Groveman BR, Orr\u00f9 CD et al (2023) Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk ofprion disease. Brain 146:2570\u20132583. https:\/\/doi.org\/10.1093\/brain\/awad101","DOI":"10.1093\/brain\/awad101"},{"key":"2212_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orru","year":"2014","unstructured":"Orru CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, Fiorini M, Pocchiari M, Monaco S, Caughey B et al (2014) A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med 371:519\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1315200","journal-title":"N Engl J Med"},{"key":"2212_CR24","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/acn3.51219","volume":"7","author":"CD Orru","year":"2020","unstructured":"Orru CD, Groveman BR, Foutz A, Bongianni M, Cardone F, McKenzie N, Culeux A, Poleggi A, Grznarova K, Perra D et al (2020) Ring trial of 2nd generation RT-QuIC diagnostic tests for sporadic CJD. Ann Clin Transl Neurol 7:2262\u20132271. https:\/\/doi.org\/10.1002\/acn3.51219","journal-title":"Ann Clin Transl Neurol"},{"key":"2212_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02451-14","author":"CD Orru","year":"2015","unstructured":"Orru CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. https:\/\/doi.org\/10.1128\/mBio.02451-14","journal-title":"MBio"},{"key":"2212_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.874734","volume":"14","author":"A Poleggi","year":"2022","unstructured":"Poleggi A, Baiardi S, Ladogana A, Parchi P (2022) The use of real-time quaking-induced conversion for the diagnosis of human prion diseases. Front Aging Neurosci 14:874734. https:\/\/doi.org\/10.3389\/fnagi.2022.874734","journal-title":"Front Aging Neurosci"},{"key":"2212_CR39","doi-asserted-by":"publisher","unstructured":"Raymond GJ, Race B, Orr\u00fa\u00fa CD, Raymond LD, Bongianni M, Fiorini M, Groveman BR, Ferrari S, Sacchetto L, Hughson AG, Monaco S, Pocchiari M, Zanusso G, Caughey B (2020) Transmission of CJD from nasal brushings but not spinal fluid or RT-QuIC product. Ann Clin Transl Neurol 7(6):932\u2013944. https:\/\/doi.org\/10.1002\/acn3.51057","DOI":"10.1002\/acn3.51057"},{"key":"2212_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orru CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"2212_CR28","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, Muller-Cramm D, Collins S, Atarashi R, Satoh K, Orru CD, Groveman BR, Zafar S et al (2016) The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc 11:2233\u20132242. https:\/\/doi.org\/10.1038\/nprot.2016.120","journal-title":"Nat Protoc"},{"key":"2212_CR29","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","volume":"388","author":"M Schmitz","year":"2023","unstructured":"Schmitz M, Silva Correia S, Hermann P, Maass F, Goebel S, Bunck T, Correia A, Lingor P, Fischer A, Zerr I (2023) Detection of prion protein seeding activity in tear fluids. N Engl J Med 388:1816\u20131817. https:\/\/doi.org\/10.1056\/NEJMc2214647","journal-title":"N Engl J Med"},{"key":"2212_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awab350","volume":"145","author":"M Schmitz","year":"2022","unstructured":"Schmitz M, Villar-Pique A, Hermann P, Escaramis G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B et al (2022) Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain 145:700\u2013712. https:\/\/doi.org\/10.1093\/brain\/awab350","journal-title":"Brain"},{"key":"2212_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12916-020-01608-8","volume":"18","author":"SM Vallabh","year":"2020","unstructured":"Vallabh SM, Minikel EV, Williams VJ, Carlyle BC, McManus AJ, Wennick CD, Bolling A, Trombetta BA, Urick D, Nobuhara CK et al (2020) Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Med 18:140. https:\/\/doi.org\/10.1186\/s12916-020-01608-8","journal-title":"BMC Med"},{"key":"2212_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209506","volume":"103","author":"SM Vallabh","year":"2024","unstructured":"Vallabh SM, Mortberg MA, Allen SW, Kupferschmid AC, Kivisakk P, Hammerschlag BL, Bolling A, Trombetta BA, Devitte-McKee K, Ford AM et al (2024) Fluid biomarkers in individuals at risk for genetic prion disease up to disease conversion. Neurology 103:e209506. https:\/\/doi.org\/10.1212\/WNL.0000000000209506","journal-title":"Neurology"},{"key":"2212_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/physiologyonline.1998.13.2.97","volume":"13","author":"B Walcott","year":"1998","unstructured":"Walcott B (1998) The lacrimal gland and its veil of tears. News Physiol Sci 13:97\u2013103. https:\/\/doi.org\/10.1152\/physiologyonline.1998.13.2.97","journal-title":"News Physiol Sci"},{"key":"2212_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","volume":"17","author":"N Watson","year":"2021","unstructured":"Watson N, Brandel JP, Green A, Hermann P, Ladogana A, Lindsay T, Mackenzie J, Pocchiari M, Smith C, Zerr I et al (2021) The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 17:362\u2013379. https:\/\/doi.org\/10.1038\/s41582-021-00488-7","journal-title":"Nat Rev Neurol"},{"key":"2212_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192013341","author":"M Winiarczyk","year":"2022","unstructured":"Winiarczyk M, Biela K, Michalak K, Winiarczyk D, Mackiewicz J (2022) Changes in tear proteomic profile in ocular diseases. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph192013341","journal-title":"Int J Environ Res Public Health"},{"key":"2212_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa022043","volume":"348","author":"G Zanusso","year":"2003","unstructured":"Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M, Fiorini M, Farinazzo A, Gardiman M, Cavallaro T, Bentivoglio M et al (2003) Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 348:711\u2013719. https:\/\/doi.org\/10.1056\/NEJMoa022043","journal-title":"N Engl J Med"},{"key":"2212_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra2119323","volume":"386","author":"I Zerr","year":"2022","unstructured":"Zerr I (2022) Laboratory diagnosis of Creutzfeldt-Jakob disease. N Engl J Med 386:1345\u20131350. https:\/\/doi.org\/10.1056\/NEJMra2119323","journal-title":"N Engl J Med"},{"key":"2212_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13167-021-00265-y","volume":"12","author":"X Zhan","year":"2021","unstructured":"Zhan X, Li J, Guo Y, Golubnitschaja O (2021) Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine. EPMA J 12:449\u2013475. https:\/\/doi.org\/10.1007\/s13167-021-00265-y","journal-title":"EPMA J"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02212-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02212-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02212-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:59:17Z","timestamp":1781629157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02212-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02212-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human tear fluid samples were approved by the local ethic committee of the University Medical Center Goettingen, Von Siebold-Str. 3, 37075 G\u00f6ttingen, No. 11\/11\/93 (prion diseases). Control TF samples were obtained through other observational studies that were also approved by the local ethics committee, University Medical Center Goettingen (No. 11\/11\/93; No. 13\/11\/12; No.10\/8\/18) and Munich (No. 9\/15; No. 2023\u2013170-S-NP). TF samples from HMC were collected under approval of the Basque Ethics Committee for research (CEIm-E, study No. PI2018195).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors had seen the manuscript and agreed to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.E. is employed by the commercial company ATLAS Molecular Pharma SL. This does not alter our adherence to the Journal\u2019s policies on sharing data and materials and did not influence in any way the work reported in this manuscript, given that the company had no role in study design, funding, and data analysis. The rest of the authors declare that there are no other financial disclosures or any other conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}